Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
national top stories
3
×
biotech
boston blog main
boston top stories
alnylam pharmaceuticals
amgen
boston
brexanalone
cholesterol
clinical data
clinical study
clinical trials
data
depression
disease
enzyme
gag
gene editing
genome editing
hunter syndrome
ids
inclisiran
jeff jonas
major depressive disorder
mental illness
mps ii
mucopolysaccharidosis ii
neuroscience
new york
new york blog main
new york top stories
pcsk9 inhibitors
phase 3 trial
postpartum depression
praluent
psychiatric disorders
regeneron pharmaceuticals
repatha
What
phase
3
×
drug
fda
morning
therapeutics
trial
approval
benefit
brexanalone
bringing
cholesterol
clears
closer
depression
editing
filing
gene
going
hits
hour
humans
inched
infusion
isn't
landmark
little
lowering
mark
market
medco
medical
medicine
medicines
nasdaq
positive
postpartum
ppd
preps
reported
reports
Language
unset
Current search:
phase
×
" national top stories "
×
@xconomy.com
4 years ago
MedCo Preps for FDA Filing as Cholesterol Drug Clears Last Two Tests
@xconomy.com
5 years ago
In Landmark Gene-Editing Study, Sangamo Reports Little Benefit
@xconomy.com
5 years ago
Sage Hits Mark in Postpartum Depression Phase 3 Trial, Stock Surges